cerebral hypoperfusion

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec

There was a trend for increased resting cerebral blood flow velocity in the candesartan group compared to declines in the lisinopril and HCTZ groups, but this did not reach statistical significance in

Effect: null; Candesartan: +1.03 cm/sec; Lisinopril: -2.12 cm/sec; HCTZ: -2.40 cm/sec